253 related articles for article (PubMed ID: 20052713)
21. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single-center experience.
Devine K; Ranganathan S; Mazariegos G; Bond G; Soltys K; Ganoza A; Sun Q; Sindhi R
Pediatr Transplant; 2020 Aug; 24(5):e13723. PubMed ID: 32424963
[TBL] [Abstract][Full Text] [Related]
22. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
Muchtar E; Kramer MR; Vidal L; Ram R; Gurion R; Rosenblat Y; Bakal I; Shpilberg O
Transplantation; 2013 Oct; 96(7):657-63. PubMed ID: 23823652
[TBL] [Abstract][Full Text] [Related]
23. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH
Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050
[TBL] [Abstract][Full Text] [Related]
24. Posttransplant lymphoproliferative disorder in pediatric patients: Survival rates according to primary sites of occurrence and a proposed clinical categorization.
L'Huillier AG; Dipchand AI; Ng VL; Hebert D; Avitzur Y; Solomon M; Ngan BY; Stephens D; Punnett AS; Barton M; Allen UD
Am J Transplant; 2019 Oct; 19(10):2764-2774. PubMed ID: 30884098
[TBL] [Abstract][Full Text] [Related]
25. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
Peters AC; Akinwumi MS; Cervera C; Mabilangan C; Ghosh S; Lai R; Iafolla M; Doucette K; Preiksaitis JK
Transplantation; 2018 Sep; 102(9):1553-1562. PubMed ID: 29485513
[TBL] [Abstract][Full Text] [Related]
26. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Romero S; Montoro J; Guinot M; Almenar L; Andreu R; Balaguer A; Beneyto I; Espí J; Gómez-Codina J; Iacoboni G; Jarque I; López-Andújar R; Mayordomo-Aranda E; Montalar J; Pastor A; Pastor M; Piñana JL; Rojas-Ferrer N; Sánchez-Lázaro I; Sandoval J; Sanz G; Sanz MÁ; Solé A; Sanz J
Leuk Lymphoma; 2019 Jan; 60(1):142-150. PubMed ID: 29966464
[TBL] [Abstract][Full Text] [Related]
27. Pathology of central nervous system posttransplant lymphoproliferative disorders: lessons from pediatric autopsies.
Gheorghe G; Radu O; Milanovich S; Hamilton RL; Jaffe R; Southern JF; Ozolek JA
Pediatr Dev Pathol; 2013; 16(2):67-73. PubMed ID: 23286282
[TBL] [Abstract][Full Text] [Related]
28. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
Weintraub L; Weiner C; Miloh T; Tomaino J; Joashi U; Benchimol C; Strauchen J; Roth M; Wistinghausen B
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e481-6. PubMed ID: 24878618
[TBL] [Abstract][Full Text] [Related]
29. Posttransplant Lymphoproliferative Disorder in Pediatric Patients: Characteristics of Disease in EBV-seropositive Recipients.
L'Huillier AG; Dipchand AI; Ng VL; Hebert D; Avitzur Y; Solomon M; Ngan BY; Yeung S; Stephens D; Punnett AS; Barton M; Allen UD
Transplantation; 2019 Nov; 103(11):e369-e374. PubMed ID: 31385930
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment.
Overkamp M; Granai M; Bonzheim I; Steinhilber J; Schittenhelm J; Bethge W; Quintanilla-Martinez L; Fend F; Federmann B
Virchows Arch; 2021 Jun; 478(6):1135-1148. PubMed ID: 33324999
[TBL] [Abstract][Full Text] [Related]
31. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
Pitman SD; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Berdeja JG; Weiss LM; Wang J
Am J Surg Pathol; 2006 Apr; 30(4):470-6. PubMed ID: 16625093
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors.
Fink SE; Gandhi MK; Nourse JP; Keane C; Jones K; Crooks P; Jöhrens K; Korfel A; Schmidt H; Neumann S; Tiede A; Jäger U; Dührsen U; Neuhaus R; Dreyling M; Borchert K; Südhoff T; Riess H; Anagnostopoulos I; Trappe RU
Am J Transplant; 2014 Nov; 14(11):2577-87. PubMed ID: 25130212
[TBL] [Abstract][Full Text] [Related]
33. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
34. Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules.
Kampers J; Orjuela-Grimm M; Schober T; Schulz TF; Stiefel M; Klein C; Körholz D; Mauz-Körholz C; Kreipe H; Beier R; Maecker-Kolhoff B
Leuk Lymphoma; 2017 Mar; 58(3):633-638. PubMed ID: 27685149
[TBL] [Abstract][Full Text] [Related]
35. Post-transplant lymphoproliferative disorders.
Singavi AK; Harrington AM; Fenske TS
Cancer Treat Res; 2015; 165():305-27. PubMed ID: 25655616
[TBL] [Abstract][Full Text] [Related]
36. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
Arita H; Izumoto S; Kinoshita M; Okita Y; Hashimoto N; Fujita T; Ichimaru N; Takahara S; Yoshimine T
Neurol Med Chir (Tokyo); 2010; 50(12):1079-83. PubMed ID: 21206182
[TBL] [Abstract][Full Text] [Related]
37. Primary central nervous system posttransplant lymphoproliferative disorders.
Castellano-Sanchez AA; Li S; Qian J; Lagoo A; Weir E; Brat DJ
Am J Clin Pathol; 2004 Feb; 121(2):246-53. PubMed ID: 14983939
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
[TBL] [Abstract][Full Text] [Related]
39. Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide.
Toyosaki M; Onizuka M; Amaki J; Shiraiwa S; Aoyama Y; Machida S; Kawai H; Murayama H; Ogiya D; Matsui K; Kawakami S; Harada K; Kondo Y; Hirabayashi K; Nakamura N; Ogawa Y; Kawada H; Ando K
Blood Cell Ther; 2019 Feb; 2(1):1-4. PubMed ID: 37969696
[TBL] [Abstract][Full Text] [Related]
40. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD; Preiksaitis JK;
Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]